U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101911101911Low-Cost Molecular Cervical Cancer Screening StudyCompletedNo Results AvailableDNA Probes|E6 Protein|Uterine Cervical Neoplasms|HPVhttps://ClinicalTrials.gov/show/NCT01231945
101912101912Investigating Molecular-Genetic Correlates of Fatigue Experienced by Cancer Patients Receiving TreatmentRecruitingNo Results AvailableCancer|Fatiguehttps://ClinicalTrials.gov/show/NCT01231932
101913101913MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Acute Leukemias of Ambiguous Lineage|Acute Myeloid Leukemia/Transient Myeloproliferative Disorder|Acute Undifferentiated Leukemia|Aggressive NK-cell Leukemia|Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegatiDrug: Akt inhibitor MK2206|Other: diagnostic laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT01231919
101914101914Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaRecruitingNo Results AvailableAdult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Childhood Supratentorial Primitive Neuroectodermal Tumor|Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Localized Ewing SarDrug: vincristine sulfate|Drug: doxorubicin hydrochloride|Drug: cyclophosphamide|Drug: ifosfamide|Drug: etoposide|Drug: topotecan hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01231906
101915101915Transplantation of Autologous Olfactory Ensheathing Cells in Complete Human Spinal Cord InjuryRecruitingNo Results AvailableComplete Spinal Cord InjuriesProcedure: olfactory mucosa ensheathing cell grafting, rehabilitation|Other: rehabilitationhttps://ClinicalTrials.gov/show/NCT01231893
101916101916School Based Malaria Control in Ugandan SchoolchildrenCompletedNo Results AvailableMalariaDrug: Four monthly IPT with dihydroartemisinin Piperaquine (DP)|Drug: Monthly IPT using DP|Drug: Placebo given every monthhttps://ClinicalTrials.gov/show/NCT01231880
101917101917Cohort Study of Clopidogrel and Proton Pump InhibitorsCompletedNo Results AvailableCoronary Heart Disease|Acute Coronary Syndrome|Drug Interactions|Clopidogrel|Proton Pump Inhibitors|Gastrointestinal Hemorrhagehttps://ClinicalTrials.gov/show/NCT01231867
101918101918Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.TerminatedNo Results AvailableAtopic DermatitisDrug: Ciclosporin|Drug: Alitretinoinhttps://ClinicalTrials.gov/show/NCT01231854
101919101919Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic AnemiaCompletedHas ResultsAplastic AnemiaDrug: cyclosporine|Other: flow cytometry|Biological: anti-thymocyte globulinhttps://ClinicalTrials.gov/show/NCT01231841
101920101920Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.CompletedNo Results AvailableCirrhosisDrug: L-carnitine|Drug: Lactulosehttps://ClinicalTrials.gov/show/NCT01231828
101921101921Coronary Flow Reserve Evaluation in PET and in MRI Scanner in Heart Transplanted Patients : Comparison With Multi-detectors ScannerRecruitingNo Results AvailableHeart DiseaseRadiation: 15O-H2O PET -|Radiation: MRIhttps://ClinicalTrials.gov/show/NCT01231815
101922101922Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Eniluracil|Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT01231802
101923101923The Neuroprotection of Remote Ischemic Preconditioning (RIPC) on Cardiac Surgery in MulticenterRecruitingNo Results AvailableCardiac Surgery PatientsProcedure: RIPC|Procedure: sham RIPChttps://ClinicalTrials.gov/show/NCT01231789
101924101924Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary BypassRecruitingNo Results AvailableHeart Valve Diseases|Cardiopulmonary BypassOther: electronic acupuncturehttps://ClinicalTrials.gov/show/NCT01231776
101925101925Acceptability Study of Vaginal Films for HIV PreventionCompletedNo Results AvailableHIV Infections|Anti-Infective AgentsOther: No intervention (not applicable)https://ClinicalTrials.gov/show/NCT01231763
101926101926Efficacy of Topical Capsaicin Cream for Stable AnginaTerminatedHas ResultsStable AnginaDrug: Capsaicin|Other: Placebo creamhttps://ClinicalTrials.gov/show/NCT01231750
101927101927Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)Enrolling by invitationNo Results AvailableUrinary Tract InfectionDrug: prulifloxacinhttps://ClinicalTrials.gov/show/NCT01231737
101928101928Topical Allstate and Nasal Allergen ChallengeWithdrawnNo Results AvailableAllergic RhinitisDevice: Allstate Nasal Spray|Device: Placebo Nasal Sprayhttps://ClinicalTrials.gov/show/NCT01231724
101929101929Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based InterventionCompletedNo Results AvailableDepression|Post-Traumatic Stress Disorder|Functional StatusBehavioral: Vets Prevailhttps://ClinicalTrials.gov/show/NCT01231711
101930101930Heart Rate Control With Esmolol in Septic ShockCompletedNo Results AvailableSeptic ShockDrug: esmolol|Other: controlhttps://ClinicalTrials.gov/show/NCT01231698
101931101931Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infectionActive, not recruitingNo Results AvailableHIV|Hepatitis C|Liver FibrosisDrug: Raltegravir|Drug: Ritonavir-boosted protease inhibitorhttps://ClinicalTrials.gov/show/NCT01231685
101932101932Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic ShockCompletedNo Results AvailableShock, SepticBiological: Routine biological analyseshttps://ClinicalTrials.gov/show/NCT01231672
101933101933Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast CancerActive, not recruitingNo Results AvailablePostmenopausal Women,|Locally Advanced or Metastatic Breast CancerDrug: Everolimus + Letrozolehttps://ClinicalTrials.gov/show/NCT01231659
101934101934Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?Active, not recruitingNo Results AvailableEpilepsy|Psychiatric or Mood Diseases or Conditionshttps://ClinicalTrials.gov/show/NCT01231646
101935101935Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)CompletedNo Results AvailableMacular Edema|Central Retinal Vein OcclusionDrug: Ozurdex|Drug: Avastinhttps://ClinicalTrials.gov/show/NCT01231633
101936101936A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaRecruitingNo Results AvailableInfluenza, HumanDrug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo|Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo|Drug: 75mg oral oseltamivir and intravenous zanamivir placebohttps://ClinicalTrials.gov/show/NCT01231620
101937101937Dutasteride Versus Placebo and Finasteride in Men With Androgenetic AlopeciaCompletedHas ResultsAndrogenetic AlopeciaDrug: 1mg Finasteride active|Drug: 0.02mg dutasteride|Drug: 0.1mg dutasteride|Drug: 0.5mg dutasteride|Drug: Finasteride placebo|Drug: Dutasteride placebohttps://ClinicalTrials.gov/show/NCT01231607
101938101938A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive TumorsRecruitingNo Results AvailableCancerDrug: GSK2118436|Drug: GSK1120212|Drug: Other approved anti-cancer agenthttps://ClinicalTrials.gov/show/NCT01231594
101939101939Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic CancerCompletedHas ResultsCancerDrug: GSK1120212|Drug: Gemcitabine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01231581
101940101940An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive TumorCompletedNo Results AvailableCancerDrug: Regimen A|Drug: Regimen B|Drug: Regimen C|Drug: Regimen Dhttps://ClinicalTrials.gov/show/NCT01231568

* Görseller ve İçerik tekif hakkına sahip olabilir